Association between Tobacco Smoking and Cognitive Functioning in Young Adults

American Journal on Addictions

Volumn 21, Issue , 2012, Pages S14-S19

  Chamberlain, Samuel R ^a   Odlaug, Brian L ^b   Schreiber, Liana R N ^b   Grant, Jon E ^b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADJUSTMENT; ADULT; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; EXECUTIVE FUNCTION; FEMALE; GAMBLING; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PLANNING; RISK ASSESSMENT; SMOKING; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY; YOUNG ADULT; ADOLESCENT; CASE CONTROL STUDY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; SHORT TERM MEMORY;

ADOLESCENT; ADULT; ATTENTION; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; NEUROPSYCHOLOGICAL TESTS; SMOKING; YOUNG ADULT;

EID: 84884291683     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/j.1521-0391.2012.00290.x     Document Type: Article

References (47)

1. Fagerström K. The epidemiology of smoking: Health consequences and benefits of cessation. Drugs. 2002; 62(suppl 2): 1-9.
2. Wipfli H, Samet JM. Global economic and health benefits of tobacco control: Part 1. Clin Pharmacol Ther. 2009; 86(3): 263-271.
3. Wipfli H, Samet JM. Global economic and health benefits of tobacco control: Part 2. Clin Pharmacol Ther. 2009; 86(3): 272-280.
4. Benowitz NL. Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther. 2008; 83(4); 531-541.
5. Wells AJ, English PB, Posner SF, et al. Misclassification rates for current smokers misclassified as nonsmokers. Am J Public Health. 1998; 88(10): 1503-1509.
6. Berrendero F, Robledo P, Trigo JM, et al. Neurobiological mechanisms involved in nicotine dependence and reward: Participation of the endogenous opioid system. Neurosci Biobehav Rev. 2010; 35(2): 220-231.
7. Mansvelder HD, vanAerde KI,Couey JJ, et al. Nicotinic modulation of neuronal networks: From receptors to cognition. Psychopharmacology (Berl). 2006; 184(3-4): 292-305.
8. Perry EK, Smith CJ, Perry RH, et al. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain. J Chem Neuroanat. 1989; 2(4)189-199.
9. Rubboli F, Court JA, Sala C, et al. Distribution of neuronal nicotinic receptor subunits in human brain. Neurochem Int. 1994; 25(1): 69-71.
10. Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol. 2000; 61(1): 75-111.
11. Chamberlain SR, Sahakian BJ. The neuropsychiatry of impulsivity. Curr Opin Psychiatry. 2007; 20(3): 255-261.
12. Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation. Annu Rev Neurosci. 2009; 32: 267-287.
13. Chamberlain SR, Robbins TW, Winder-Rhodes S, et al. Translational approaches to frontostriatal dysfunction in attentiondeficit/ hyperactivity disorder using a computerized neuropsychological battery. Biol Psychiatry. 2011; 69(12): 1192-1203.
14. Heishman SJ. What aspects of human performance are truly enhanced by nicotine? Addiction. 1998; 93(3): 317-320.
15. Heishman SJ, Kleykamp BA, Singleton EG. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl). 2010; 210(4): 453-469.
16. Berkman LF, Seeman TE, Albert M, et al. High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol. 1993; 46(10): 1129-1140.
17. Launer LJ, Feskens EJ, Kalmijn S, et al. Smoking, drinking, and thinking: The Zutphen Elderly Study. Am J Epidemiol. 1996; 143(3): 219-227.
18. Edelstein SL, Kritz-Silverstein D, Barrett-Connor E. Prospective association of smoking and alcohol use with cognitive function in an elderly cohort. J Womens Health. 1998; 7(10): 1271-1281.
19. EliasMF, Beiser A,Wolf PA, et al. The preclinical phase ofAlzheimer disease: A22-year prospective study of theFraminghamCohort. Arch Neurol. 2000; 57(6): 808-813.
20. Deary IJ, Pattie A, Taylor MD, et al. Smoking and cognitive change from age 11 to age 80. J Neurol Neurosurg Psychiatry. 2003; 74(7): 1006-1007.
21. Collins N, Sachs-Ericsson N, Preacher KJ, et al. Smoking increases risk for cognitive decline among community-dwelling older Mexican Americans. Am J Geriatr Psychiatry. 2009; 17(11): 934-942.
22. Huang CQ, Dong BR, Zhang YL, et al. Association of cognitive impairment with smoking, alcohol consumption, tea consumption, and exercise among Chinese nonagenarians/centenarians. Cogn Behav Neurol. 2009; 22(3): 190-196.
23. Yaffe K, Fiocco AJ, Lindquist K, et al. Predictors of maintaining cognitive function in older adults: TheHealthABCstudy. Neurology. 2009; 72(23): 2029-2035.
24. Lee Y, Back JH, Kim J, et al. Systematic review of health behavioral risks and cognitive health in older adults. Int Psychogeriatr. 2010; 22(2): 174-187.
25. Slotkin TA. Nicotine and the adolescent brain: Insights from an animal model. Neurotoxicol Teratol. 2002; 24(3): 369-384.
26. Trauth JA, McCook EC, Seidler FJ, Slotkin TA. Modeling adolescent nicotine exposure: Effects on cholinergic systems in rat brain regions. Brain Res. 2000; 873(1): 18-25.
27. Jacobsen LK, Krystal JH, Mencl WE, et al. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry. 2005; 57(1): 56-66.
28. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of cigarette smoking in young adults - A comparison with pre-drug performance. Neurotoxicol Teratol. 2006; 28(4): 517-525.
29. Weiser M, Zarka S, Werbeloff N, et al. Cognitive test scores in male adolescent cigarette smokers compared to non-smokers: A population-based study. Addiction. 2010; 105(2): 358-363.
30. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M. I. N. I. ): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59(suppl 20): 22-33 quiz 34-57.
31. Coull JT, Middleton HC, Robbins TW, et al. Clonidine and diazepam have differential effects on tests of attention and learning. Psychopharmacology (Berl). 1995; 120(3): 322-332.
32. OwenAM,Downes JJ, Sahakian BJ, et al. Planning and spatialworking memory following frontal lobe lesions in man. Neuropsychologia. 1990; 28(10): 1021-1034.
33. Logan GD, Cowan WB, Davis KA. On the ability to inhibit simple and choice reaction time responses: A model and a method. J Exp Psychol Hum Percept Perform. 1984; 10(2): 276-291.
34. Aron AR, Poldrack RA. The cognitive neuroscience of response inhibition: relevance for genetic research in attentiondeficit/ hyperactivity disorder. Biol Psych. 2005; 57(11): 1285-1292.
35. Aron AR, Durston S, Eagle DM, et al. Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. J Neurosci. 2007; 27(44): 11860-11864.
36. Williams-Gray CH, Hampshire A, Robbins TW, et al. Catechol Omethyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease. JNeurosci. 2007; 27(18): 4832-4838.
37. Manes F, Sahakian B, Clark L, et al. Decision-making processes following damage to the prefrontal cortex. Brain. 2002; 125(Pt 3): 624-639.
38. Clark L, Bechara A, Damasio H, et al. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain. 2008; 131(Pt 5): 1311-1322.
39. Harrison EL, Desai RA, McKee SA. Nondaily smoking and alcohol use, hazardous drinking, and alcohol diagnoses among young adults: Findings from the NESARC. Alcohol Clin Exp Res. 2008; 32(12): 2081-2087.
40. Castner SA, Smagin GN, Piser TM, et al. Immediate and sustained improvements in working memory after selective stimulation of alpha7 nicotinic acetylcholine receptors. Biol Psychiatry. 2011; 69(1): 12-18.
41. Wing VC, Sacco KA, George TP. Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia. Schizophr Res. 2011. 1; 128: 171-172.
42. Hong LE, Schroeder M, Ross TJ, et al. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Schizophr Bull. 2011; 37(2): 416-425.
43. Businelle MS, Apperson MR,Kendzor DE, et al. The relative impact of nicotine dependence, other substance dependence, and gender on Bechara Gambling Task performance. Exp Clin Psychopharmacol. 2008; 16(6): 13-20.
44. CoolsR,Robbins TW. Chemistry of the adaptive mind. Philos Transact A Math Phys Eng Sci. 2004; 362(1825): 2871-2888.
45. Herman AI, SofuogluM. Cognitive effects of nicotine: genetic moderators. Addict Biol. 2010; 15(3): 250-265.
46. Shiffman S, West R, Gilbert D. SRNT Work Group on the Assessment of Craving andWithdrawal in Clinical Trials. Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials. Nicotine Tob Res. 2004; 6(4): 599-614. Review.
47. Coulston CM, Perdices M, Tennant CC. The neuropsychology of cannabis and other substance use in schizophrenia: Review of the literature and critical evaluation of methodological issues. Aust N Z J Psychiatry. 2007; 41(11): 869-884. Review.